Donate Toggle Menu

The February 2012 edition, anchored by Carrie Konosky, focuses on the many valuable contributions of kidney cancer researchers over the past two decades, as reflected in a keynote address to peers by W. Marston Linehan, MD.

Bill Bro highlights FDA approval of a new drug to treat a certain type of kidney cancer and brings to light a controversial survey that suggests doctors aren’t always forthright in dealing with patients.